|
|
|
|
LEADER |
01943nam a22004215i 4500 |
001 |
000293291 |
005 |
20210609105517.0 |
007 |
cr nn 008mamaa |
008 |
100301s2010 ne | s |||| 0|eng d |
020 |
|
|
|a 9789048126781
|
024 |
7 |
|
|a 10.1007/978-90-481-2678-1
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Synthetic Biology :
|b the technoscience and its societal consequences /
|c edited by Markus Schmidt, Alexander Kelle, Agomoni Ganguli-Mitra, Huib de Vriend.
|
250 |
|
|
|a 1st ed. 2010.
|
260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2010.
|
300 |
|
|
|a VIII, 186 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a That Was the Synthetic Biology That Was -- An Introduction to Synthetic Biology -- Computational Design in Synthetic Biology -- The Ethics of Synthetic Biology: Outlining the Agenda -- Do I Understand What I Can Create? -- Security Issues Related to Synthetic Biology -- The Intellectual Commons and Property in Synthetic Biology -- Governing Synthetic Biology: Processes and Outcomes -- Synthetic Biology and the Role of Civil Society Organizations -- Summary and Conclusions.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Biotechnology.
|
650 |
|
0 |
|a Quality control.
|
650 |
|
0 |
|a Reliability.
|
650 |
|
0 |
|a Industrial safety.
|
650 |
|
0 |
|a Medical ethics.
|
650 |
|
0 |
|a Economic policy.
|
650 |
1 |
4 |
|a Biomedicine, general.
|
650 |
2 |
4 |
|a Biotechnology.
|
650 |
2 |
4 |
|a Quality Control, Reliability, Safety and Risk.
|
650 |
2 |
4 |
|a Theory of Medicine/Bioethics.
|
650 |
2 |
4 |
|a R & D/Technology Policy.
|
700 |
1 |
|
|a Schmidt, Markus.
|e editor.
|
700 |
1 |
|
|a Kelle, Alexander.
|e editor.
|
700 |
1 |
|
|a Ganguli-Mitra, Agomoni.
|e editor.
|
700 |
1 |
|
|a de Vriend, Huib.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|